Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study

Michael Westhoff, Maren Friedrich, Jörg I Baumbach, Michael Westhoff, Maren Friedrich, Jörg I Baumbach

Abstract

The high sensitivity of the methods applied in breath analysis entails a high risk of detecting analytes that do not derive from endogenous production. Consequentially, it appears useful to have knowledge about the composition of inhaled air and to include alveolar gradients into interpretation. The current study aimed to standardise sampling procedures in breath analysis, especially with multicapillary column ion-mobility spectrometry (MCC-IMS), by applying a simultaneous registration of inhaled air and exhaled breath. A "double MCC-IMS" device, which for the first time allows simultaneous analysis of inhaled air and exhaled breath, was developed and tested in 18 healthy individuals. For this, two BreathDiscovery instruments were coupled with each other. Measurements of inhaled air and exhaled breath in 18 healthy individuals (mean age 46±10.9 years; nine men, nine women) identified 35 different volatile organic compounds (VOCs) for further analysis. Not all of these had positive alveolar gradients and could be regarded as endogenous VOCs: 16 VOCs had a positive alveolar gradient in mean; 19 VOCs a negative one. 12 VOCs were positive in >12 of the healthy subjects. For the first time in our understanding, a method is described that enables simultaneous measurement of inhaled air and exhaled breath. This facilitates the calculation of alveolar gradients and selection of endogenous VOCs for exhaled breath analysis. Only a part of VOCs in exhaled breath are truly endogenous VOCs. The observation of different and varying polarities of the alveolar gradients needs further analysis.

Conflict of interest statement

Conflict of interest: M. Westhoff has nothing to disclose. M. Friedrich is member of the staff of Braun Melsungen AG, Branch Dortmund, Center of Competence Breath Analysis, Dortmund. J.I. Baumbach is member of the staff of Braun Melsungen AG, Branch Dortmund, Center of Competence Breath Analysis, Dortmund.

Copyright ©The authors 2022.

Figures

FIGURE 1
FIGURE 1
Schematic experimental setup consisting of two BreathDiscovery, two REDMON and two SpiroScout instruments. The rear SpiroScout was turned around 180° and connected to the proximal one. Each SpiroScout was linked to one BreathDiscovery, that is connected to a REDMON which provided the operating gas. The red line indicates the path of the inhaled air moving towards the patient through the SpiroScouts and reaching the BreathDiscovery 01. The blue line shows the path of exhaled breath moving away from the patient and reaching the corresponding BreathDiscovery.
FIGURE 2
FIGURE 2
Comparison of volume and flows during inspiration and expiration by mirroring them on top of each other. The left y-axis shows the flow, while the right y-axis indicates the volume (flow rate over time). The time in seconds is shown on the x-axis. The flow is proportional to L·s−1 and the volume to litres. Although the instruments are not calibrated, they are equal. Δa and Δb indicate the rise of the flow at expiration and inspiration, respectively. The duration of either expiration or inspiration is indicated by ΔC and ΔD. Each SpiroScout should recognise both directions of flow, even if only one is collected and analysed. The area of the integrals Ex (expiration) and In (inspiration) show that although their flows are mirrored and should be the same, they differ slightly from each other. a.u.: arbitrary units.
FIGURE 3
FIGURE 3
Three-dimensional spectrum of a) inhaled air and b) exhaled breath. The y-axes indicate the retention time (RT) in seconds; the x-axes the drift time in 1/K0 Vs·cm−2. The third axis, the peak intensity, increases from white to yellow colour. At expiration, peak P1 alone can be visually recognised as more intense compared to the inspiration. However, peak P5 can be seen more intensely during inspiration (cf. black frames). For detailed peak analysis intensities have to be measured and compared.
FIGURE 4
FIGURE 4
Peak images of all peaks found from all 18 healthy test subjects. The images are created from the peak windows from the three-dimensional spectrum of each measurement. Peak intensities reach from white being the lowest intensity to yellow being the highest. The top 18 rows result from inhaled air (rows at the height of the red arrow); the lower 18 show exhaled breath (rows at the height of the blue arrow). Each column shows one out of 35 peaks, ascending from left to right and starting at peak P0. The black frame circles peak P1. Here the difference between the more intense peaks on inhaled air compared to exhaled breath can be made visually.

References

    1. Horváth I, Barnes PJ, Loukides S, et al. . European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J 2017; 49: 1600965. doi:10.1183/13993003.00965-2016
    1. Wallace L, Buckley T, Pellizzari E, et al. . Breath measurements as volatile organic compound biomarkers. Environ Health Perspect 1996; 104: Suppl. 5, 861–869.
    1. Bunkowski A, Maddula S, Davies AN, et al. . One-year time series of investigations of analytes within human breath using ion mobility spectrometry. Int J Ion Mobil Spec 2010; 13: 141–148. doi:10.1007/s12127-010-0052-7
    1. Westhoff M, Rickermann M, Franieck E, et al. . Time series of indoor analytes and influence of exogeneous factors on interpretation of breath analysis using ion mobility spectrometry (MCC/IMS). Int J Ion Mobil Spec 2019; 22: 39–49. doi:10.1007/s12127-019-00243-1
    1. Westhoff M, Rickermann M, Litterst P, et al. . Exogenous factors of influence on exhaled breath analysis by ion-mobility spectrometry (MCC/IMS). Int J Ion Mobil Spec 2019; 22: 59–69. doi:10.1007/s12127-019-00247-x
    1. Gaida A, Holz O, Nell C, et al. . A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. J Breath Res 2016; 10: 026006. doi:10.1088/1752-7155/10/2/026006
    1. Bunkowski A, Bödeker S, Bader S, et al. . MCC/IMS signals in human breath related to sarcoidosis – results of a feasibility study using an automated peak finding procedure. J Breath Res 2009; 3: 046001. doi:10.1088/1752-7155/3/4/046001
    1. Phillips M, Greenberg J, Awad J. Metabolic and environmental origins of volatile organic compounds in breath. J Clin Pathol 1994; 47: 1052–1053. doi:10.1136/jcp.47.11.1052
    1. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 1997; 247: 272–278. doi:10.1006/abio.1997.2069
    1. Pizzini A, Filipiak W, Wille J, et al. . Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. J Breath Res 2018; 12: 036002. doi:10.1088/1752-7163/aaa4c5
    1. Jünger M, Bödeker B, Baumbach JI. Peak assignment in multi-capillary column–ion mobility spectrometry using comparative studies with gas chromatography–mass spectrometry for VOC analysis. Anal Bioanal Chem 2010; 396: 471–482. doi:10.1007/s00216-009-3168-z
    1. Westhoff M, Litterst P, Freitag L, et al. . Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study. J Physiol Pharmacol 2007; 58: 739–751.
    1. Westhoff M, Litterst P, Freitag L, et al. . Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009; 64: 744–748. doi:10.1136/thx.2008.099465
    1. Baumbach, JI. Process analysis using ion mobility spectrometry. Anal Bioanal Chem 2006; 384: 1059–1070.
    1. Baumbach JI. Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res 2009; 3: 034001. doi:10.1088/1752-7155/3/3/034001
    1. Bödeker B, Baumbach JI. Analytical description of IMS-signals. Int J Ion Mobil Spec 2009; 12: 103–108. doi:10.1007/s12127-009-0024-y
    1. Bödeker B, Vautz W, Baumbach JI. Peak finding and referencing in MCC/IMS-data. Int J Ion Mobil Spec 2008; 11: 83–87. doi:10.1007/s12127-008-0012-7
    1. Bödeker B, Vautz W, Baumbach JI. Peak comparison in MCC/IMS-data – searching for potential biomarkers in human breath data. Int J Ion Mobil Spec 2008; 11: 89–93. doi:10.1007/s12127-008-0013-6
    1. Bödeker B, Vautz W, Baumbach JI. Visualisation of MCC/IMS-data. Int J Ion Mobil Spec 2008; 11: 77–81. doi:10.1007/s12127-008-0011-8
    1. Bader S, Urfer W, Baumbach JI. Reduction of ion mobility spectrometry data by clustering characteristic peak structures. J Chemometrics 2006; 20: 128–135. doi:10.1002/cem.998
    1. Bader S, Urfer W, Baumbach JI. Processing ion mobility spectrometry data to characterize group differences in a multiple class comparison. Int J Ion Mobil Spec 2005; 8: 1–4.
    1. Phillips M, Greenberg, Sabas M. Alveolar gradient of pentane in normal human breath. Free Radic Res 1994; 20: 333–337. doi:10.3109/10715769409145633
    1. Bödeker B, Davies AN, Maddula S, et al. . Biomarker validation – room air variation during human breath investigations. Int J Ion Mobil Spec 2010; 13: 177–184. doi:10.1007/s12127-010-0044-7
    1. Maurer F, Wolf A, Fink T, et al. . Wash-out of ambient air contaminations for breath measurements. J Breath Res 2014; 8: 027107. doi:10.1088/1752-7155/8/2/027107
    1. Phillips M, Altorki N, Austin JH, et al. . Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark 2007; 3: 95–109. doi:10.3233/CBM-2007-3204
    1. Phillips M, Cataneo RN, Cummin AR, et al. . Detection of lung cancer with volatile markers in the breath. Chest 2003; 123: 2115–2123. doi:10.1378/chest.123.6.2115
    1. Philips M, Cataneo RN, Chaturvedi A,et al. . Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. PLoS One 2013; 8: e75274. doi:10.1371/journal.pone.0075274
    1. Ligor M, Ligor T, Bajtarevic A, et al. . Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med 2009; 47: 550–560. doi:10.1515/CCLM.2009.133
    1. Bajtarevic A, Ager C, Pienz M, et al. . Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009; 9: 348. doi:10.1186/1471-2407-9-348
    1. Barker M, Hengst M, Schmid J,et al. . Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J 2006; 27: 929–936. doi:10.1183/09031936.06.00085105
    1. Spaněl P, Dryahina K, Smith D. A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath. J Breath Res 2013; 7: 017106. doi:10.1088/1752-7155/7/1/017106
    1. Westhoff M, Litterst P, Bödeker B, et al. . Breath analysis by MCC/IMS in obstructive sleep apnoea. Somnologie 2009; 13: Suppl. 2, 63–64.
    1. Filipiak W, Filipiak A, Sponring A, et al. . Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. J Breath Res 2014; 8: 027111. doi:10.1088/1752-7155/8/2/027111
    1. Fuchs P, Loeseken C, Schubert JK, et al. . Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 2010; 126: 2663–2670. doi:10.1002/ijc.24970
    1. Machado RF, Laskowski D, Deffenderfer O,et al. . Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005; 171: 1286–1291. doi:10.1164/rccm.200409-1184OC
    1. Van Berkel JJ, Dallinga JW, Möller GM, et al. . A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 2010; 104: 557–563. doi:10.1016/j.rmed.2009.10.018
    1. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis – focus on volatile organic compounds. Clim Chim Acta 2004; 347: 25–39. doi:10.1016/j.cccn.2004.04.023

Source: PubMed

3
Abonnere